Exelixis (EXEL)
(Delayed Data from NSDQ)
$21.93 USD
+0.24 (1.11%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $21.93 0.00 (0.00%) 6:34 PM ET
3-Hold of 5 3
B Value C Growth F Momentum D VGM
Income Statements
Fiscal Year end for Exelixis, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,830 | 1,611 | 1,435 | 988 | 968 |
Cost Of Goods | 73 | 58 | 53 | 36 | 33 |
Gross Profit | 1,758 | 1,553 | 1,382 | 951 | 935 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,587 | 1,352 | 1,095 | 841 | 565 |
Income After Depreciation & Amortization | 171 | 201 | 287 | 110 | 369 |
Non-Operating Income | 87 | 33 | 7 | 21 | 29 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 258 | 234 | 294 | 131 | 398 |
Income Taxes | 50 | 52 | 63 | 19 | 77 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 208 | 182 | 231 | 112 | 321 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 208 | 182 | 231 | 112 | 321 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 197 | 222 | 300 | 119 | 378 |
Depreciation & Amortization (Cash Flow) | 26 | 21 | 14 | 9 | 8 |
Income After Depreciation & Amortization | 171 | 201 | 287 | 110 | 369 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 321.46 | 324.56 | 322.36 | 318.00 | 315.01 |
Diluted EPS Before Non-Recurring Items | 0.65 | 0.56 | 0.72 | 0.35 | 1.02 |
Diluted Net EPS (GAAP) | 0.65 | 0.56 | 0.72 | 0.35 | 1.02 |
Fiscal Year end for Exelixis, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 425.23 | 479.65 | 471.92 | 469.85 | 408.79 |
Cost Of Goods | 21.26 | 21.75 | 18.77 | 17.71 | 14.32 |
Gross Profit | 403.97 | 457.90 | 453.15 | 452.14 | 394.47 |
SG&A, R&D, and Dept/Amort Expenses | 374.51 | 376.11 | 470.73 | 374.29 | 365.65 |
Income After SG&A, R&D, and Dept/Amort Expenses | 29.46 | 81.79 | -17.58 | 77.85 | 28.82 |
Non-Operating Income | 19.81 | 21.25 | 23.40 | 22.54 | 19.45 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 49.27 | 103.04 | 5.82 | 100.39 | 48.28 |
Income Taxes | 11.95 | 17.52 | 4.78 | 19.21 | 8.25 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 37.32 | 85.52 | 1.04 | 81.18 | 40.03 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 37.32 | 85.52 | 1.04 | 81.18 | 40.03 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 305.53 | 313.02 | 319.25 | 327.31 | 326.28 |
Diluted EPS Before Non-Recurring Items | 0.12 | 0.27 | 0.00 | 0.25 | 0.12 |
Diluted Net EPS (GAAP) | 0.12 | 0.28 | 0.00 | 0.25 | 0.12 |